Back to search

Article

Host-Derived Immunometabolic Biomarkers Identify Prognostic Profiles under Immunotherapy in Advanced NSCLC: the SARC-LUNG Study

2026-06-29

Abstract excerpt

<title>Abstract</title> <p>Background Immune checkpoint inhibitors (ICIs) improve outcomes in advanced non-small cell lung cancer (NSCLC), but predictive biomarkers remain limited. Host-derived immunometabolic factors may modulate response to ICIs. Methods In the prospective SARC-LUNG study, 40 patients with advanced NSCLC treated with first-line ICIs (± chemotherapy) underwent longitudinal assessment of circul...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0808033d-cf61-58f9-9a19-a676d25d690b
DOI
10.21203/rs.3.rs-10072857/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Host-Derived Immunometabolic Biomarkers Identify Prognostic Profiles under Immunotherapy in Advanced NSCLC: the SARC-LUNG StudyDOI 10.21203/rs.3.rs-10072857/v1
Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase InhibitorsSemantic proximity
A plasma proteomic signature of cancer-related sarcopenia implicates the IGFBP axis in muscle dysfunctionSemantic proximity
Characterization of pretreatment cachexia through cytokine and nutritional analysis in lung cancer: the Marató cohortSemantic proximity
Serum cholesterol-riched apolipoprotein-B (apoB) containing lipoproteins predict the response to immune checkpoints inhibitors (ICIs) in non-small cell lung cancer (NSCLC) : A retrospective analysisSemantic proximity
Multimodal Analysis Reveals Differential Immuno-Metabolic Features in Lung Squamous Cell Carcinoma and AdenocarcinomaSemantic proximity
A Latent Class Analysis Based on Nutritional and Inflammatory Profiles Predicts Efficacy in Advanced NSCLC Treated with Immune Checkpoint InhibitorsSemantic proximity
Tumor Transcriptome in Patients with Lower Pectoralis Muscle Area Reveals IL-8 as a Prognostic Biomarker in Non-Small Cell Lung CancerSemantic proximity
A Novel Prognostic Scoring System Based on F-18 FDG PET/CT Volumetric Parameters, Sarcopenia, and Clinical Variables in Patients Receiving Immunotherapy for Advanced Solid Tumors: The Immunotherapy Prognostic Score (IPS)Semantic proximity
Real-world survival outcomes to first-line chemoimmunotherapy and biomarker analysis in extensive-stage small-cell lung cancerSemantic proximity
Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapySemantic proximity
Genetic Variability in the IGF-1 Axis Modulates Cancer-Associated Cachexia and PrognosisSemantic proximity
Bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitorsSemantic proximity
Select a neighboring publication to make it the new centre.